Title : Crizotinib versus Alectinib for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Pub. Date : 2022

PMID : 34915469






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The crizotinib group reported higher rates of constipation, nausea, diarrhea, vomiting, peripheral edema, dysgeusia, visual impairment and levels of alanine aminotransferase and aspartate aminotransferase as well as greater decreases in appetite and neutrophil count. Crizotinib glutamic--pyruvic transaminase Homo sapiens